Clinical Trials Directory

Trials / Sponsors / Hansa Biopharma AB

Hansa Biopharma AB

Industry · 16 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and
Long Term Efficacy and Safety
Phase 32023-07-03
RecruitingImlifidase Prior to Kidney Transplant in Highly Sensitised Children
Kidney Transplantation in Highly Sensitized Patients
Phase 22023-06-02
Active Not RecruitingSurvival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx
Kidney Transplantation in Highly Sensitized Patients
2023-04-21
TerminatedA Study With Imlifidase in Anti-GBM Disease
Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome
Phase 32022-12-22
TerminatedA Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation
Kidney Transplantation in Highly Sensitized Patients
Phase 22022-12-16
Active Not RecruitingEfficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Coh
Kidney Transplantation in Highly Sensitized Patients
Phase 32022-04-19
CompletedRenal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney T
Kidney Transplantation in Highly Sensitized Patients
Phase 32021-10-14
TerminatedAn Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR
Kidney Transplant Rejection
2021-01-20
CompletedA Study of Imlifidase in Patients With Guillain-Barré Syndrome
Guillain-Barré Syndrome (GBS)
Phase 22019-11-12
CompletedAn Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Pa
Kidney Transplant Rejection
Phase 22019-04-30
CompletedA Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
Kidney Transplant Failure and Rejection
2018-06-27
TerminatedIdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients
Purpura, Thrombotic Thrombocytopenic
Phase 22016-09-01
CompletedA Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatc
Kidney Failure, Chronic
Phase 22016-06-01
CompletedStudy to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation
End Stage Kidney Disease
Phase 22015-06-01
CompletedPhase II Study, Evaluation of Safety and Efficacy of IdeS in Chronic Kidney Disease
Chronic Kidney Disease
Phase 22014-06-01
CompletedSafety Study on IdeS in Healthy Volounteers
Healthy
Phase 12013-02-01